Pretrichodermamides D-F from a Marine Algicolous Fungus Penicillium sp. Apixaban for the Treatment of Chronic Disseminated Intravascular Coagulation: A Report of Two CasesJanjetovic S, Holstein K, Dicke C, Bokemeyer C, Langer FHAMOSTASEOLOGIE. The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literature.Calabrò F, Albers P, Bokemeyer C, Martin C, Einhorn L, Horwich A, Krege S, Schmoll H, Sternberg C, Daugaard GEUR UROL. 2018;110(6):638-648. 1. Prävention der HarnsäurenephropathieAlsdorf W, Sökler M, Bokemeyer C2021. 2011;6(1):199-202. 2021;13:17588359211020547. 2015;26(1):81-87. 2016;97(3):239-44. 1. Cyclin D1 gene amplification is highly homogeneous in breast cancerBurandt E, Grünert M, Lebeau A, Choschzick M, Quaas A, Jänicke F, Müller V, Scholz U, Bokemeyer C, Petersen C, Geist S, Paluchowski P, Wilke C, Heilenkötter U, Simon R, Sauter G, Wilczak WBREAST CANCER-TOKYO. Metastatic Germ Cell Cancer: The Intermediate-Prognosis Risk CategoryBokemeyer C, Seidel C2015. Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 TreatmentGhandili S, Schönlein M, Lütgehetmann M, Wiesch J, Becher H, Bokemeyer C, Sinn M, Weisel K, Leypoldt LCANCERS. 2016;19(7-8):64. 2016;15:48. Late Treatments Effects and Cancer Survivor Care in young adultsBeck J, Bokemeyer C, Langer T2021. Taschenbuch Onkologie. ProstatakarzinomHautmann R, Küfer R, Bokemeyer C, Panse J, Belka C, Hinkelbein W2011. 2023;7:e2200436. 2017;35(8):1167-1175. 2020;38(12):1322-1331. KeimzelltumoreHonecker F, Bokemeyer C, Krege S, Classen J2018. 1. WebProf. Cancer-related anemia: pathogenesis, prevalence and treatmentBirgegård G, Aapro M, Bokemeyer C, Dicato M, Drings P, Hornedo J, Krzakowski M, Ludwig H, Pecorelli S, Schmoll H, Schneider M, Schrijvers D, Shasha D, Van Belle SONCOLOGY. EAU Guidelines on Testicular Cancer - 2022 editionLaguna M, Albers P, Algaba F, Bokemeyer C, Boormans J, di Nardo D, Fischer S, Fizazi K, Gremmels H, Leao R, Nicol D, Nicolai N, Oldenburg J, Tandstad T2022. Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working PartyNecchi A, Miceli R, Bregni M, Bokemeyer C, Berger L, Oechsle K, Schumacher K, Kanfer E, Bourhis J, Massard C, Laszlo D, Montoro J, Flechon A, Arpaci F, Secondino S, Wuchter P, Dreger P, Crysandt M, Worel N, Kruger W, Ringhoffer M, Unal A, Nagler A, Campos A, Wahlin A, Michieli M, Sucak G, Donnini I, Schots R, Ifrah N, Badoglio M, Martino M, Raggi D, Giannatempo P, Rosti G, Pedrazzoli P, Lanza FBONE MARROW TRANSPL. De Gruyter, 219-228. WeichteilsarkomeKopp H, Bokemeyer C, Hohenberger P, Müller A2018. Cancer Cells Expressing Oncogenic Rat Sarcoma Show Drug-Addiction Toward Epidermal Growth Factor Receptor Antibodies Mediated by Sustained MAPK SignalingTintelnot J, Metz S, Trentmann M, Oberle A, von Wenserski L, Schultheiß C, Braig F, Kriegs M, Fehse B, Riecken K, Bokemeyer C, Stein A, Binder MFRONT ONCOL. Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)Janning M, Süptitz J, Albers-Leischner C, Delpy P, Tufman A, Velthaus-Rusik J, Reck M, Jung A, Kauffmann-Guerrero D, Bonzheim I, Brändlein S, Hummel H, Wiesweg M, Schildhaus H, Stratmann J, Sebastian M, Alt J, Buth J, Esposito I, Berger J, Tögel L, Saalfeld F, Wermke M, Merkelbach-Bruse S, Hillmer A, Klauschen F, Bokemeyer C, Buettner R, Wolf J, Loges SANN ONCOL. Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate CancerHennigs J, Minner S, Tennstedt P, Löser R, Huland H, Klose H, Graefen M, Schlomm T, Sauter G, Bokemeyer C, Honecker FSCI REP-UK. 2020;9(6):4315-4322. 2009. Das offizielle Magazin der Deutschen Krebsgesellschaft e.V.. 2014;29:457. 1. 2023;14:1158449. EORTC study 40015.Köhne C, De Greve J, Hartmann J, Lang I, Vergauwe P, Becker K, Braumann D, Joosens E, Müller L, Janssens J, Bokemeyer C, Reimer P, Link H, Späth-Schwalbe E, Wilke H, Bleiberg H, Van Den Brande J, Debois M, Bethe U, Van Cutsem EANN ONCOL. WebInfos Beruflicher Werdegang von Frau Prof. Dr. med. Differentiation and development of human female germ cells during prenatal gonadogenesis: an immunohistochemical studyStoop H, Honecker F, Cools M, de Krijger R, Bokemeyer C, Looijenga LHUM REPROD. Nausea und Emesis bei urogenitalen TumorenBokemeyer C2014. 2008;31(5):237-241. Acute megakaryoblastic leukemia in a patient with xeroderma pigmentosum: discussion of pathophysiological, prognostic, and toxicological aspects.Janjetovic S, Bacher U, Haalck T, Janning M, Bokemeyer C, Fiedler WACTA HAEMATOL-BASEL. 2005;16(8):1326-33. 2021;105(3-4):181-191. Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab.Tejpar S, Celik I, Schlichting M, Sartorius U, Bokemeyer C, Eric VJ CLIN ONCOL. A novel mouse model for inhibition of DOHH mediated hypusine modification reveals crucial function for embryonic development, proliferation and oncogenic transformationSievert H, Pällmann N, Miller K, Hermans-Borgmeyer I, Venz S, Sendoel A, Preukschas M, Schweizer M, Böttcher S, Janiesch P, Streichert T, Walther R, Hengartner M, Manz M, Brümmendorf T, Bokemeyer C, Balabanov M, Hauber J, Duncan K, Balabanov SDIS MODEL MECH. 2022;63(3):664-671. Chemotherapie und systemische Therapie bei Lebermetastasen - Kolorektales KarzinomFolprecht G, Bokemeyer C2010. Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upOldenburg J, Fosså S, Nuver J, Heidenreich A, Schmoll H, Bokemeyer C, Horwich A, Beyer J, Kataja VANN ONCOL. [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group.Oechsle K, Hartmann M, Brenner W, Venz S, Weissbach L, Franzius C, Kliesch S, Mueller S, Krege S, Heicappell R, Bares R, Bokemeyer C, De Wit MJ CLIN ONCOL. ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.Minner S, Enodien M, Sirma H, Lübke A, Krohn A, Mayer P, Simon R, Tennstedt P, Müller J, Scholz L, Brase J, Liu A, Schlüter H, Pantel K, Schumacher U, Bokemeyer C, Steuber T, Graefen M, Sauter G, Schlomm TCLIN CANCER RES. 2011;11:30. 2007;43(2):258-270. Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram ProjectSjoquist K, Renfro L, Simes R, Tebbutt N, Clarke S, Seymour M, Adams R, Maughan T, Saltz L, Goldberg R, Schmoll H, Van Cutsem E, Douillard J, Hoff P, Hecht J, Tournigand C, Punt C, Koopman M, Hurwitz H, Heinemann V, Zalcberg JJNCI-J NATL CANCER I. Multimodal exercise training during myeloablative chemotherapy: a prospective randomized pilot trialOechsle K, Aslan Z, Suesse Y, Jensen W, Bokemeyer C, de Wit MSUPPORT CARE CANCER. Moderne Krebstherapie: aktueller Stand und zukünftige EntwicklungBokemeyer C, Hiddemann WDEUT MED WOCHENSCHR. 2022;25(12):16–21. Das offizielle Magazin der Deutschen Krebsgesellschaft e.V.. 2014;29(1):1. WebStartseite > Universitäres Cancer Center Hamburg (UCCH) Unsere Patienten im Mittelpunkt Wir heißen Sie herzlich im Hubertus Wald Tumorzentrum – Universitäres Cancer Center … Das Zertifizierungssystem der Deutschen Krebsgesellschaft: Nutzen und WeiterentwicklungRückher J, Bokemeyer C, Fehm T, Graeven U, Wesselmann SONKOLOGE. Uni-Med, 86-96. A systematic review of available evidenceWinter C, Zengerling F, Busch J, Heinzelbecker J, Pfister D, Ruf C, Lackner J, Albers P, Kliesch S, Schmidt S, Bokemeyer CWORLD J UROL. Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.Preukschas M, Hagel C, Schulte A, Riecken K, Lamszus K, Sievert H, Pällmann N, Bokemeyer C, Hauber J, Balabanov M, Balabanov SPLOS ONE. 2021;138(11):996-999. Taschenbuch Onkologie. 2020;19(1):67. Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" ( 72 h): findings from the MONITOR-GCSF studyLudwig H, Gascón P, Bokemeyer C, Aapro M, Boccadoro M, Denhaerynck K, Krendyukov A, MacDonald K, Abraham ISUPPORT CARE CANCER. Thoughts of death and suicidality among patients with cancer: examining subtypes and their association with mental disordersVehling S, Mehnert-Theuerkauf A, Glaesmer H, Bokemeyer C, Oechsle K, Härter M, Koch-Gromus UPSYCHO-ONCOLOGY. Decrease of CD4(+)FOXP3(+) T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor.Freier E, Weber C, Nowottne U, Horn C, Bartels K, Meyer S, Hildebrandt Y, Luetkens T, Cao Y, Pabst C, Muzzulini J, Schnee B, Brunner-Weinzierl M, Marangolo M, Bokemeyer C, Deter H, Atanackovic DPSYCHONEUROENDOCRINO. Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate CancerDyshlovoy S, Pelageev D, Hauschild J, Sabutskii Y, Khmelevskaya E, Krisp C, Kaune M, Venz S, Borisova K, Busenbender T, Denisenko V, Schlüter H, Bokemeyer C, Graefen M, Polonik S, Anufriev V, Amsberg GMAR DRUGS. Tumore des UrogenitaltraktsBokemeyer C, Oing C2015. 2006;29(12):557-61. Renale Toxizität antineoplastischer SubstanzenAlsdorf W, Bokemeyer C, Lipp H2021. 2014;9(7):e100469. 2005;131(11):715-22. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.Stang A, Fischbach R, Teichmann W, Bokemeyer C, Braumann DEUR J CANCER. Kapitel 11 - Tumore des UrogenitaltraktsBokemeyer C, Oing C2017. 2006;17(6):1007-13. 2009;9:311. 2015;6(8):6341-58. Supportive care in patients with cancer during the COVID-19 pandemicAapro M, Lyman G, Bokemeyer C, Rapoport B, Mathieson N, Koptelova N, Cornes P, Anderson R, Gascón P, Kuderer NESMO OPEN. New guidelines on anaemia management in patients with cancer: How do these affect clinical practice?Birgegård G, Bokemeyer CONCOLOGY. 2007;109(4):1701-1711. 2022;6(2):. Germ-cell tumors.Lorch A, Beyer J, Bokemeyer CNEW ENGL J MED. 2022;40(12):2853-2861. Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemiaLatuske E, Stamm H, Klokow M, Vohwinkel G, Muschhammer J, Bokemeyer C, Jücker M, Kebenko M, Fiedler W, Wellbrock JONCOTARGET. 2022;16(6):1401-1413. Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study)Aapro M, Ludwig H, Bokemeyer C, Gascón P, Boccadoro M, Denhaerynck K, Krendyukov A, Gorray M, MacDonald K, Abraham IANN ONCOL. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Ståhl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, Mulder D, Pieter H, Maria D, de Wit M, de Wit R, Derigs H, Dieckmann K, Dieing A, Droz J, Fenner M, Fizazi K, Flechon A, Fosså S, Muro D, Garcia X, Gauler T, Geczi L, Gerl A, Germa-Lluch J, Gillessen S, Hartmann J, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Joffe J, Jones W, Kisbenedek L, Klepp O, Kliesch S, Koehrmann K, Kollmannsberger C, Kuczyk M, Laguna P, Galvis O, Loy V, Mason M, Mead G, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof G, Ares L, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz H, Schmidberger H, Schmoll H, Schrader M, Sedlmayer F, Skakkebaek N, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, von der Maase HEUR UROL. The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)Seidel C, Daugaard G, Nestler T, Tryakin A, Fedyanin M, Fankhauser C, Hermanns T, Aparicio J, Heinzelbecker J, Paffenholz P, Heidenreich A, De Giorgi U, Cathomas R, Lorch A, Fingerhut A, Gayer F, Bremmer F, Giannatempo P, Necchi A, Raggi D, Aurilio G, Casadei C, Hentrich M, Tran B, Dieckmann K, Brito M, Ruf C, Mazzocca A, Vincenzi B, Stahl O, Bokemeyer C, Oing CWORLD J UROL. Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study GroupFenner M, Oing C, Dieing A, Gauler T, Oechsle K, Lorch A, Hentrich M, Kopp H, Bokemeyer C, Honecker FJ CANCER RES CLIN. Weitere Infos und Kontaktmöglichkeiten finden Sie immer auch auf den jeweiligen Webseiten der … Platinum-refractory germ cell tumors: an update on current treatment options and developmentsOing C, Alsdorf W, von Amsberg G, Oechsle K, Bokemeyer CWORLD J UROL. Biological basis and early clinical results of immunotherapy for cisplatin-resistant germ cell cancerOing C, Bokemeyer CCURR OPIN UROL. An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcomaReichardt P, Oechsle K, Pink D, Bokemeyer C, Schneller F, Issels R, Kanz L, Hartmann JINVEST NEW DRUG. 2013;36(11):663-8. 2022;127(3):408-421. 2022;163:1-15. 2013;31(30):3764-75. Bone metastases in germ cell tumor patients.Oechsle K, Bokemeyer C, Kollmannsberger C, Mayer F, Berger L, Oing C, Honecker FJ CANCER RES CLIN. Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upOldenburg J, Berney D, Bokemeyer C, Climent M, Daugaard G, Gietema J, De Giorgi U, Haugnes H, Huddart R, Leão R, Sohaib A, Gillessen S, Powles TANN ONCOL. 2021;26(2):e327-e332. 2013;31(3):661-668. 2018;41 Suppl 3:1. Primary NK/T cell lymphoma nasal type of the stomach with skin involvement: a case reportKobold S, Merz H, Tiemann M, Mahuad C, Bokemeyer C, Koop I, Fiedler WRare Tumors. 2017;25(6):1819-1828. Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR/ABL1 negative.Wellbrock J, Schultze A, Schafhausen P, Otterstetter S, Dierlamm J, Bokemeyer C, Brümmendorf T, Fiedler W, Loges SBRIT J HAEMATOL. WebHämatologie und internistische Onkologie Palliativmedizin. Physical exercise and therapy in terminally ill cancer patients: a retrospective feasibility analysisJensen W, Bialy L, Ketels G, Baumann F, Bokemeyer C, Oechsle KSUPPORT CARE CANCER. Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus PaperWörmann B, Bokemeyer C, Burmeister T, Köhne C, Schwab M, Arnold D, Blohmer J, Borner M, Brucker S, Cascorbi I, Decker T, de Wit M, Dietz A, Einsele H, Eisterer W, Folprecht G, Hilbe W, Hoffmann J, Knauf W, Kunzmann V, Largiadèr C, Lorenzen S, Lüftner D, Moehler M, Nöthen M, Pox C, Reinacher-Schick A, Scharl A, Schlegelberger B, Seufferlein T, Sinn M, Stroth M, Tamm I, Trümper L, Wilhelm M, Wöll E, Hofheinz RONCOL RES TREAT. 2009;101(6):1147-1155. Das offizielle Magazin der Deutschen Krebsgesellschaft e.V.. 2014;29:361. Symptom burden in long-term germ cell tumor survivorsOechsle K, Hartmann M, Mehnert A, Oing C, Bokemeyer C, Vehling SSUPPORT CARE CANCER. Lectin histochemistry of metastatic adenocarcinomas of the lung.Thoem I, Schult-Kronefeld O, Burkholder I, Goern M, Andritzky B, Blonski K, Kugler C, Edler L, Bokemeyer C, Schumacher U, Laack ELUNG CANCER. 2016;(2):28-29. 2022;20(12):. 2016;34(2):144-150. WebUKE jukebox - Privatstation MKG, HNO & UCH (5A) Privatstation MKG, HNO & UCH (5A) Die Station mit abwechslungsreicher, anspruchsvoller Pflege und einem sympathisch … 2021;13(16):3941. Letzte Aktualisierung aus dem FIS: 06.06.2023 - 00:38 Uhr, RETTUNGSDIENST/NOTARZT 112 ZENTRALE NOTAUFNAHME (0 - 24 Uhr, Hauptgebäude O10) +49 (0) 40 7410 - 0 Notfallpraxis am UKE (Informationen und Hinweise)Notaufnahme Kinder-UKEGebäude O47 +49 (0) 40 7410 - 0 Lageplan Bereichsfinder Wegweiser SICHERHEITSDIENST DES UKE +49 (0) 40 7410 - 55555, LAGEPLAN Orientierungsplan Hauptgebäude O10 Ihre Anreisemöglichkeiten Ihre Anreise mit öffentlichen Verkehrsmitteln: Hamburger Verkehrsverbund (HVV) StadtRad Hamburg Airport Hamburg, Corona-Virus | COVID-19 Patientenbroschüre Das UKE in Leichter Sprache UKE Life Kontaktdaten | Orientierung, SPENDENKONTO UKE gGmbHIBAN: DE54 2005 0550 1234 3636 36 Hamburger Sparkasse ONLINE-SPENDE WEITERE INFORMATIONEN, MARTINISTRASSE 52 20246 HAMBURG BITTE BEACHTEN: BEI DER EINGABE IN DAS NAVIGATIONSSYSTEM 20251 ALS POSTLEITZAHL EINGEBENVermittlung +49 (0) 40 7410 - 0 2021;44(9):495-502. RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminomaAndreassen C, Lorenzen M, Nielsen J, Kafai Yahyavi S, Toft B, Ingerslev L, Clemmensen C, Rasmussen L, Bokemeyer C, Juul A, Jørgensen A, Blomberg Jensen MBRIT J CANCER. Ramin Madanchi. Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy.Seimetz D, Lindhofer H, Bokemeyer CCANCER TREAT REV. Aufl. 2013;63(6):977-982. 2008;32(8):1200-1206. WebAsklepios wurde im Jahr 1985 gegründet und ist heute mit rund 170 Einrichtungen und 67.000 Mitarbeiter:innen ein führender digitaler Gesundheitskonzern in Deutschland. Krege S (Hrsg.). 2009;32(3):14-18. WebDorbaumstraße 300, 48157 Münster Telefon: 0251 / 32 87-0 | Fax: -299 Website: fachklinik-hornheide.de E-Mail: post @ fachklinik-hornheide.de 2022;107(12):2870-2883. Beck J, Bokemeyer C, Langer T (Hrsg.). Aufl. 2010;116(17):4114-4121. Challenges Faced by Prehospital Emergency Physicians Providing Emergency Care to Patients with Advanced Incurable DiseasesKamphausen A, Roese H, Oechsle K, Issleib M, Zöllner C, Bokemeyer C, Ullrich AEMERG MED INT. Cerebral metastases in non-seminomatous germ cell tumour patients undergoing primary high-dose chemotherapy.Oechsle K, Kollmannsberger C, Honecker F, Boehlke I, Bokemeyer CEUR J CANCER. Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilizationDyshlovoy S, Hauschild J, Amann K, Tabakmakher K, Venz S, Walther R, Guzii A, Makarieva T, Shubina L, Fedorov S, Stonik V, Bokemeyer C, Balabanov S, Honecker F, Amsberg GONCOTARGET. A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancerBokemeyer C, Stein A, Ridwelski K, Atanackovic D, Arnold D, Wöll E, Ulrich A, Fischer R, Krüger C, Schuhmacher CGASTRIC CANCER. Clinical response to ibrutinib is accompanied by normalization of the T-cell environment in CLL-related autoimmune cytopeniaSchliffke S, Akyüz N, Ford C, Mährle T, Thenhausen T, Krohn-Grimberghe A, Knop S, Bokemeyer C, Binder MLEUKEMIA. 2012;13(12):1250-9. Inhibition of protein disulfide isomerase with PACMA-31 regulates monocyte tissue factor through transcriptional and posttranscriptional mechanismsBeckmann L, Mäder J, Voigtlaender M, Klingler F, Schulenkorf A, Lehr C, Regenhardt J, Bokemeyer C, Ruf W, Rolling C, Langer FTHROMB RES. 2005;34(2):128-37. Erstlinientherapie intensiv-therapierbarer AML Patient*innenModemann F, Ghandili S, Bokemeyer C, Fiedler WInFo Hämatologie + Onkologie. 2019;2019:3456471. 2017;17(1):93. 2008;93(3):423-430. 2021;19(1):147. Intraclass correlation metrics for the accuracy of algorithmic definitions in a computerized decision support system for supportive cancer care.Aapro M, Abraham I, MacDonald K, Soubeyran P, Foubert J, Bokemeyer C, Muenzberg M, Joanna V, Turner MSUPPORT CARE CANCER. 2011;17(7):1-8. Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway.Oliveira-Ferrer L, Hauschild J, Fiedler W, Bokemeyer C, Nippgen J, Celik I, Schuch GJ EXP CLIN CANC RES. Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PETBokemeyer C, Kollmannsberger C, Oechsle K, Dohmen B, Pfannenberg A, Claussen C, Bares R, Kanz LBRIT J CANCER.
Uniklinik Düsseldorf Hno Station, Articles U